Market Place
Sourcing Support
Lupin gains Health Canada approval for biosimilar Pegfilgrastim
24 Aug 2024 //
EXPRESSPHARMA
Coherus Announces U.S. Launch of UDENYCA ONBODY
21 Feb 2024 //
GLOBENEWSWIRE
Mylan`s Biologic Fulphila (pegfilgrastim) Receives Approval in the U.S.
13 Oct 2023 //
FDA
Sandoz`s Biologic Ziextenzo (pegfilgrastim) Receives Approval in the U.S.
09 Oct 2023 //
FDA
BLA Resubmitted to FDA for On-Body Injector Presentation of Pegfilgrastim-cbqv
06 Oct 2023 //
ONCLIVE
Aurobindo`s subsidiary to withdraw mkt authorization for EU 2 biosimilar
25 Jun 2023 //
INDIANPHARMAPOST
CMS grants Fresenius Kabi permanent, product-specific Q-Code for Stimufend®
16 May 2023 //
BUSINESSWIRE
FDA Approves UDENYCA Autoinjector
06 Mar 2023 //
GLOBENEWSWIRE
Stimufend® (pegfilgrastim-fpgk) Now Available in the United States
16 Feb 2023 //
BUSINESSWIRE
Coherus` Biologic Udenyca (Pegfilgrastim) Receives Approval in the U.S.
28 Nov 2022 //
FDA
Amgen`s Neulasta gains another biosimilar competitor as sales slip
09 Sep 2022 //
ENDPTS
Fresenius Kabi receives U.S. FDA approval for biosimilar Stimufend
07 Sep 2022 //
PRESS RELEASE
Fresenius`s Biologic Stimufend (Pegfilgrastim) Receives Approval in the U.S.
01 Sep 2022 //
FDA
BeyondSpring Presents New Data for the Use of Plinabulin and Pegfilgrastim
29 Aug 2022 //
GLOBENEWSWIRE
Kashiv Biosciences Achieves Second U.S. Biosimilar Approval with FYLNETRA
31 May 2022 //
BUSINESSWIRE
Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA
27 May 2022 //
BUSINESSWIRE
BeyondSpring Pharmaceuticals Announces Analysis of New Data on the Plinabulin
10 Dec 2021 //
GLOBENEWSWIRE
Lupin enters into distribution and marketing agreement with Biomm
06 Dec 2021 //
LUPIN
Amgen’s Biosimilar Trends Report shows benefit of competition from biosimilars
23 Sep 2021 //
PMLIVE
J&J, Amgen and Roche face growing biosimilar competition
12 Aug 2021 //
FIERCEPHARMA
New Report Suggests Biosimliar Drugs Push Biologic Treatment Prices Lower
18 Jun 2021 //
FORBES
BeyondSpring Announces Final Positive Data from the CIN Program of Plinabulin
10 Jun 2021 //
GLOBENEWSWIRE
BeyondSpring Announces a Presentation of PROTECTIVE-2 Phase 3 Data
08 Jun 2021 //
GLOBENEWSWIRE
BeyondSpring Announces Positive Data from Ph3 Program of Plinabulin
07 Jun 2021 //
PRESS RELEASE
Pelmeg developed with aid of regulatory reform
19 Mar 2021 //
GABIONLINE
Amgen Inc`s Neulasta (Pegfilgrastim) Receives Supplemental Approval In US
08 Feb 2021 //
FDA
Amgen Inc`s Neulasta (Pegfilgrastim) Receives Supplemental Approval In US
09 Jan 2021 //
FDA
EyePoint Presents Positive Data of Yutiq and Dexycu in Four Poster at AAO 2020
16 Nov 2020 //
NEWS
BeyondSpring`s Plinabulin effective in preventing chemo-induced neutropenia
24 Sep 2020 //
GLOBENEWSWIRE
Hospira`s Nyvepria (Pegfilgrastim) Receives Supplemental Approval in US
13 Jun 2020 //
FDA
FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA™
10 Jun 2020 //
BUSINESSWIRE
BeyondSpring E-Poster Presented at 2020 ASCO Virtual Scientific Program
02 Jun 2020 //
GLOBENEWSWIRE
FDA Accepts for Review Fresenius Kabi’s BLA Submission for Pegfilgrastim
27 May 2020 //
BUSINESSWIRE
Fresenius Kabi’s regulatory submission for pegfilgrastim biosimilar accepted EMA
22 May 2020 //
PRESS RELEASE
Study Says that Conversion of Intermediate-Risk FN Patients to Pegfilgrastim
15 May 2020 //
BIGMOLECULEWATCH
Biocon, Mylan launch cancer drug in Canada
29 Apr 2020 //
ECONOMIC TIMES
Biocon, Mylan launch cancer drug in Australia
13 Apr 2020 //
PHARMABIZ
Pfizer Moves to Dismiss Amgen’s Suit Over Proposed Neulasta Biosimilar
18 Mar 2020 //
BIGMOLECULEWATCH
US Biosimilar Launches About to Turn a Corner
16 Mar 2020 //
RAPS
Amgen Sues Pfizer Over Proposed Neulasta Biosimilar
14 Feb 2020 //
BIGMOLECULEWATCH
Biocon, Mylan get USFDA nod for pegfilgrastim drug substance licence
11 Jan 2020 //
ECONOMIC TIMES
Amgen`s Neulasta (pegfilgrastim) Receives Supplemental Approval In US
03 Jan 2020 //
FDA
Mundipharma`s Pegfilgrastim Receives Approval In Europe
19 Dec 2019 //
EMA
US biosimilar launches about to turn a corner
10 Dec 2019 //
ENDPTS
Biocon sees a sweet spot with its affordable insulin in US
05 Dec 2019 //
THE ECONOMIC TIMES
Volume with low cost is Biocon Biologics big plan
01 Dec 2019 //
THE ECONOMIC TIMES
USFDA approves Biocon drug Pegfilgrastim from new Bengaluru facility
27 Nov 2019 //
MONEY CONTROL
FDA grants Sandoz approval for Ziextenzo in oncology care
06 Nov 2019 //
PHARMA TIMES
Novartis gets U.S. nod for long-delayed Amgen copycat
06 Nov 2019 //
REUTERS
Sandoz`s Ziextenzo (pegfilgrastim-bmez) Receives Supplemental Approval in US
06 Nov 2019 //
FDA
BeyondSpring commences late-stage study of Plinabulin for preventing chemo
23 Oct 2019 //
SEEKINGALPHA
Coherus Biosciences Udenyca (Pegfilgrastim-Cbqv) Receives Approval in US
19 Oct 2019 //
FDA
Amgen Inc. v. Coherus BioSciences Inc. (Fed. Cir. 2019)
12 Aug 2019 //
PATENTDOCS
